4
Changes in Ownership
NRX Pharmaceuticals, Inc. Filed Acc 0001415889-22-011778
CHIEF FINANCIAL OFFICER bought 16,337 shares at an average $1.11 ($18,215)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| VAN VOORHEES SETH CHIEF FINANCIAL OFFICER | 2022-11-25 | Purchase | +8,716 | $1.12 | $9,762 | 8,716 | I: show line 1 in the form |
| VAN VOORHEES SETH CHIEF FINANCIAL OFFICER | 2022-11-25 | Purchase | +600 | $1.10 | $660 | 9,316 | I: show line 2 in the form |
| VAN VOORHEES SETH CHIEF FINANCIAL OFFICER | 2022-11-25 | Purchase | +7,021 | $1.11 | $7,793 | 16,377 | I: show line 3 in the form |
| Open-market purchases · 16,337 sh · avg $1.11 · $18,215 | |||||||
Loading xslF345X03/form4-11282022_121119.xml…